The World Health Organization (WHO) is currently seeking to establish permanent vaccine production capacity in regions where this is currently mostly absent.
Under the initiative targeting low and middle-income countries, WHO plans to expand capacity to produce COVID-19 vaccines and scale-up manufacturing to increase global access.
President Paul Kagame this week told the Independent Panel on Pandemic Preparedness and Response, co-chaired by Helen Clark and Ellen Johnson Sirleaf, that the only way to ensure vaccine equity is to produce more vaccines where they are needed.
“Rwanda is working with partners to bring the first mRNA manufacturing facility to Africa. So long as Africa remains dependent on other regions for vaccines, we will always be at the back of the queue, whenever there is scarcity,” President Kagame said.
Dr. Tharcisse Mpunga, Rwanda’s Minister of State in Charge of Primary Healthcare, said, “The government is looking for a way to produce the vaccine from Rwanda. It is one way to acquire the vaccine for Rwanda but also for Africa. There is hope. Rwanda is negotiating with partners who are willing to manufacture the vaccines from Rwanda. I cannot say exactly when but there is hope that the negotiations will be fruitful.”
Rwanda needs at least 13 million doses of the COVID-19 vaccine to inoculate 60 percent of the population, about 7.5 million people, by June 2022. So far, only 4 percent have received the first dose of the vaccine.